Next Generation Sequencing Sample Preparation

Next Generation Sequencing Sample Preparation Market Outlook

The global Next Generation Sequencing (NGS) Sample Preparation market is projected to reach USD 4.51 billion by 2035, growing at a robust CAGR of 17.2% during the forecast period from 2025 to 2035. This growth is primarily driven by the increasing prevalence of genetic disorders and the rising demand for personalized medicine. Furthermore, advancements in sequencing technologies, which have substantially reduced the cost of genome sequencing, are propelling the market. As healthcare systems around the world embrace precision medicine, the demand for effective sample preparation methods is surging. Additionally, rising investments in genomics research and applications across various industries, such as agriculture and pharmaceuticals, further contribute to the market expansion.

Growth Factor of the Market

The growth of the Next Generation Sequencing Sample Preparation market can be attributed to several key factors. Firstly, the rapid advancements in sequencing technologies have significantly enhanced the accuracy and efficiency of genomic analyses. This technological evolution has led to the development of sophisticated sample preparation kits that simplify complex processes, making them more accessible for laboratories of all sizes. Secondly, the increasing incidence of chronic diseases and genetic disorders has heightened the demand for reliable diagnostic tools, driving investments in NGS technologies. Thirdly, the rise of personalized medicine has prompted healthcare providers to look for innovative solutions that offer tailored treatment plans based on genetic information. Moreover, government initiatives aimed at promoting genomics research are fueling market growth by providing funding and support for research projects. Lastly, the increasing adoption of NGS in agricultural applications, such as crop improvement and livestock genetics, is opening up new avenues for growth within the market.

Key Highlights of the Market

• The global NGS sample preparation market is anticipated to grow significantly, reflecting a CAGR of 17.2% from 2025 to 2035.
• Technological advancements in sequencing methodologies are enhancing the efficiency of sample preparation processes.
• Personalized medicine and genomics research are main drivers for increasing market demand.
• Growing investments in research and development by both public and private sectors are contributing to market expansion.
• The utilization of NGS in agricultural research is emerging as a new growth driver for the market.

By Product Type

Library Preparation Kits:

Library preparation kits are essential in the NGS sample preparation process, as they facilitate the conversion of DNA or RNA samples into a format suitable for sequencing. These kits typically include reagents and protocols necessary for fragmenting nucleic acids, adding adapters, and enriching the DNA or RNA libraries. The growing demand for these kits is driven by their ability to streamline the preparation process, improve sequencing outcomes, and reduce turnaround times. Furthermore, the introduction of automation solutions in library preparation is enhancing the reproducibility and efficiency of workflows, which is making these kits increasingly popular among research institutions and clinical laboratories.

DNA Fragmentation:

DNA fragmentation is a critical step in NGS sample preparation, as it ensures that the nucleic acid material is of an appropriate size for sequencing. The global demand for DNA fragmentation services and reagents is increasing due to the necessity of obtaining a balanced representation of genomic sequences. Innovations in fragmentation methods, such as mechanical, enzymatic, and chemical approaches, are enhancing the precision of this process. Additionally, the integration of advanced technologies that allow for controlled fragment size distribution has further fueled the market for DNA fragmentation products. As researchers continue to seek high-quality data, the importance of effective DNA fragmentation techniques cannot be overstated.

End Repair:

End repair is a vital process in the preparation of DNA libraries for NGS, as it involves repairing the ends of fragmented DNA molecules to ensure compatibility with sequencing adapters. The growing focus on generating high-quality sequencing libraries has led to an increased demand for end repair reagents and kits. Innovations in enzymatic solutions that facilitate efficient end repair, along with user-friendly protocols, are key factors driving market growth. As laboratories strive for accuracy and reproducibility in their sequencing results, the significance of effective end repair processes is becoming increasingly evident.

A-Tailing:

A-tailing is another crucial step in the NGS sample preparation process where a single adenine (A) nucleotide is added to the 3' ends of DNA fragments. This process is critical for ensuring that the fragments can effectively bind to sequencing adapters, which contain complementary thymine (T) overhangs. The rising demand for A-tailing reagents and kits can be attributed to the growing emphasis on achieving high-quality sequencing libraries that yield reliable data. Manufacturers are focusing on developing optimized A-tailing enzymes that enhance efficiency and minimize bias, which is essential for producing accurate genomic information.

Size Selection:

Size selection is crucial for obtaining the right fragment sizes prior to sequencing, as it helps remove unwanted fragments and enriches the library for the desired size range. The market for size selection products is expanding as laboratories recognize the importance of this step in ensuring that sequencing results are representative and high-quality. Various methods, including gel-based and bead-based size selection, offer varying degrees of efficiency and ease of use. Innovations that facilitate high-throughput size selection are particularly appealing to research centers engaged in large-scale genomic projects, driving continued investment in this segment of the market.

Others:

The "Others" category in the NGS sample preparation market encompasses a variety of ancillary processes and tools that support sample preparation. This may include reagents for purification, quantification, and normalization of nucleic acids, as well as additional kits for specialized applications. The demand in this segment is growing, as researchers look for comprehensive solutions that can address their specific sample preparation needs. As the NGS technology landscape continues to evolve, the integration of various tools and reagents into a single workflow is becoming increasingly important for achieving optimal results.

By Application

Diagnostics:

Diagnostics represent one of the most significant applications of NGS sample preparation, with the technology being increasingly utilized for the detection and characterization of genetic disorders, cancers, and infectious diseases. The rising prevalence of these conditions globally has created a pressing need for accurate and timely diagnostic tools. NGS enables comprehensive genomic profiling, allowing for the identification of genetic mutations that may inform treatment decisions. The growing acceptance of NGS in clinical settings is driving investment in sample preparation technologies, as laboratories strive to meet regulatory requirements and ensure high-quality results.

Drug Discovery:

The application of NGS sample preparation in drug discovery is gaining momentum as pharmaceutical companies seek innovative solutions to accelerate the development of new therapeutics. NGS enables researchers to understand the genetic basis of diseases, facilitating the identification of novel drug targets and biomarkers. The ability to analyze complex genomic data is essential for developing effective treatments tailored to individual patients. As the pharmaceutical industry increasingly adopts NGS technologies, the demand for efficient sample preparation methods that can support large-scale studies is expected to rise significantly.

Biomarker Discovery:

Biomarker discovery is a critical area where NGS sample preparation plays a significant role, as it enables the identification of genetic markers associated with diseases. The increasing focus on precision medicine is driving investments in research aimed at discovering novel biomarkers that can predict disease susceptibility, progression, and treatment response. NGS technologies provide the resolution required for detecting subtle genomic alterations, making them invaluable for biomarker studies. As the need for reliable biomarkers rises, so does the demand for robust sample preparation methods that can ensure high-quality genomic data.

Agricultural & Animal Research:

NGS sample preparation is also being increasingly applied in agricultural and animal research, where it is used to improve crop varieties and livestock genetics. The ability to analyze the genomes of plants and animals offers insights that can lead to higher yields, disease resistance, and improved quality. The ongoing challenges posed by climate change and food security are driving research in this area, with governmental and private investments supporting genomics initiatives. The demand for efficient and reliable sample preparation technologies is anticipated to grow as researchers focus on leveraging genomics for sustainable agricultural practices.

Others:

The "Others" category in NGS applications includes a range of fields such as microbial genomics, metagenomics, and environmental studies. These applications are becoming increasingly important as researchers seek to understand the complexities of microbial communities and their roles in various ecosystems. The versatility of NGS technology allows for the exploration of diverse biological questions, driving the need for effective sample preparation methods that can adapt to varying sample types and research objectives. As interest in these areas continues to grow, the market for NGS sample preparation in "Others" applications is expected to expand significantly.

By Distribution Channel

Direct Sales:

Direct sales channels play a crucial role in the distribution of NGS sample preparation products, allowing manufacturers to establish direct relationships with customers. This channel enables companies to provide personalized support, training, and effective communication regarding product usage. Direct sales are particularly beneficial for specialized products that require technical expertise and guidance. The increasing focus on customer satisfaction and tailored service is driving demand for this distribution method, as laboratories seek to optimize their workflows and ensure the successful implementation of NGS technologies.

Distributors:

Distributor channels are vital for the widespread availability of NGS sample preparation products, as they connect manufacturers with a broader customer base. Distributors often have established networks and relationships within specific regions, facilitating the marketing and sale of NGS technologies. This channel is especially important for manufacturers looking to penetrate new markets or reach smaller laboratories that may not have direct access to specialized products. As the demand for NGS technologies continues to grow, distributors are positioned to play a critical role in ensuring that customers have access to the latest sample preparation solutions.

Online Retail:

The online retail channel is rapidly gaining popularity in the NGS sample preparation market, driven by the convenience it offers to customers. As laboratories increasingly turn to e-commerce platforms to procure their supplies, manufacturers and distributors are capitalizing on the growing trend by establishing robust online sales channels. The ability to compare products, read reviews, and conduct transactions with ease has made online retail an appealing option for many researchers. Furthermore, the rise of digital marketing and the increasing accessibility of online platforms are expected to further propel the growth of this distribution channel in the coming years.

By Sample Type

DNA:

DNA is a primary sample type used in NGS sample preparation, as it serves as the foundation for sequencing applications across various fields, including diagnostics, research, and forensics. The demand for DNA sample preparation products is expanding due to the increasing prevalence of genetic testing and the need for accurate genomic analyses. With advancements in DNA extraction and library preparation methods, laboratories are able to obtain high-quality DNA suitable for sequencing, which is critical for successful outcomes. Innovations in this area continue to drive the market, as researchers seek solutions that streamline workflows while minimizing contamination risks.

RNA:

RNA is another vital sample type in NGS sample preparation, as it enables the study of gene expression, transcriptomics, and the discovery of non-coding RNAs. The demand for RNA sample preparation products is on the rise as researchers aim to better understand the complexities of gene regulation and the functional roles of RNA molecules. However, RNA is more susceptible to degradation than DNA, which underscores the importance of utilizing high-quality reagents and protocols during sample preparation. As the importance of RNA sequencing continues to grow, companies are focusing on developing innovative solutions that enhance the stability and integrity of RNA samples throughout the preparation process.

ChIP-Seq:

ChIP-Seq (Chromatin Immunoprecipitation Sequencing) is an important application in the NGS sample preparation market, enabling researchers to study protein-DNA interactions and the epigenetic landscape of genomes. The demand for ChIP-Seq sample preparation products is driven by the increasing focus on understanding regulatory mechanisms that govern gene expression. As researchers seek to unravel the complexities of chromatin structure and function, the need for specialized reagents that facilitate effective ChIP-Seq workflows is growing. Innovations in this area are expected to enhance the reliability and efficiency of ChIP-Seq experiments, fueling further market growth.

Whole Genome Sequencing:

Whole Genome Sequencing (WGS) is a comprehensive approach used in NGS sample preparation to analyze the entirety of an organism's genomic content. The demand for WGS has surged due to its applications in fields such as personalized medicine, genetic research, and population genomics. The increasing focus on population-scale sequencing initiatives is driving the need for effective sample preparation methods that can accommodate large-scale projects. As the technology continues to evolve, manufacturers are developing solutions that enhance the efficiency of WGS sample preparation while ensuring high-quality data generation.

Others:

The "Others" category in sample types includes various specialized applications, such as metagenomic sequencing and environmental sampling. These applications require tailored sample preparation methods that can accommodate diverse biological materials. The growing interest in studying microbial diversity and the impact of environmental factors on ecosystems is driving demand in this segment. As researchers continue to explore innovative applications of NGS technologies, the market for specialized sample preparation methods is expected to grow, expanding the overall landscape of the NGS sample preparation market.

By Region

The regional analysis of the Next Generation Sequencing Sample Preparation market reveals significant variation in growth rates and market dynamics across different areas. In North America, the market is expected to dominate, accounting for approximately 42% of the global market share by 2035. The growth in this region is fueled by the presence of advanced healthcare infrastructure, substantial investments in genomics research, and the increasing adoption of NGS technologies in clinical settings. The CAGR for North America is projected to be around 18.1% during the forecast period, making it a key player in the NGS sample preparation market.

Europe is following closely, with a projected market share of about 30% by 2035. The region's growth can be attributed to the increasing focus on personalized medicine and genomic research initiatives supported by government funding programs. The European market is expected to grow at a CAGR of 16.5%, driven by the need for advanced diagnostic tools and the rising prevalence of genetic disorders. The Asia Pacific region is also set to witness considerable growth, projected to capture around 20% of the global market share. With a CAGR of 19.0%, this region is emerging as a hub for biotechnology innovation, supported by rapid technological advancements and a growing awareness of genomic medicine.

Opportunities

The Next Generation Sequencing Sample Preparation market is poised for significant opportunities in the coming years, particularly driven by the ongoing advancements in technology and the increasing applications of NGS across various fields. One of the most promising opportunities lies in the growing demand for personalized medicine, which relies heavily on genomic data for treatment customization. As healthcare providers and researchers continue to explore the potential of genomics in tailoring therapies, there will be a heightened need for efficient and reliable sample preparation methods that can accommodate the diverse requirements of genomic analyses. This trend opens avenues for companies specializing in NGS technologies to expand their product offerings and develop innovative solutions that cater to the needs of clinical laboratories and research institutions.

Moreover, the rise of collaborative research initiatives is creating an environment ripe for innovation and development in the NGS sample preparation market. By partnering with academic institutions, healthcare organizations, and research centers, companies can leverage their expertise and resources to advance the capabilities of NGS technologies. These partnerships can facilitate access to new markets and promote the adoption of cutting-edge sample preparation methods. Additionally, the increasing focus on environmental genomics, such as the study of biodiversity and conservation efforts, is presenting new opportunities for NGS applications. As researchers seek to understand the intricate relationships within ecosystems, the demand for specialized sample preparation products tailored to environmental studies will continue to grow.

Threats

Despite the promising growth prospects of the Next Generation Sequencing Sample Preparation market, several threats could pose challenges to its expansion. One significant threat is the rapid pace of technological advancements, which may lead to market saturation as new players enter the space with innovative solutions. Established companies must continually invest in research and development to stay ahead of emerging competitors and maintain their market positions. Additionally, the regulatory landscape surrounding genomic technologies is evolving, and any changes in regulations could impact the approval processes for NGS products, potentially leading to delays in market entry or increased compliance costs.

Another potential threat is the rising cost of raw materials and reagents necessary for sample preparation. Fluctuations in supply chains can disrupt production and lead to increased prices for end-users, limiting the accessibility of NGS technologies, especially in emerging markets. Furthermore, there is a risk of cybersecurity threats as laboratories increasingly adopt digital solutions for data management and analysis. The potential for data breaches and loss of sensitive genomic information can undermine trust in NGS technologies and impede market growth. Companies must implement robust security measures to protect their systems and maintain customer confidence in their products.

Competitor Outlook

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Qiagen N.V.
• PerkinElmer, Inc.
• Roche Diagnostics
• New England Biolabs, Inc.
• Bio-Rad Laboratories, Inc.
• Genomatix Software GmbH
• Macrogen, Inc.
• Oxford Nanopore Technologies Ltd.
• Bioneer Corporation
• Zymo Research Corp.
• Takara Bio, Inc.
• 107 Genomics, Inc.

The competitive landscape of the Next Generation Sequencing Sample Preparation market is characterized by a diverse array of players, ranging from established multinational corporations to innovative startups. Key players such as Illumina and Thermo Fisher Scientific dominate the market with their extensive portfolios of sample preparation products and robust research capabilities. These companies focus on continuous innovation to enhance the efficiency and reliability of their sample preparation technologies. They invest significantly in research and development to provide cutting-edge solutions that meet the evolving needs of researchers and clinicians in genomic studies. Additionally, partnerships and collaborations are common strategies employed by these companies to strengthen their market positions and expand their product offerings.

Illumina, Inc., as a market leader, is renowned for its comprehensive range of NGS sample preparation products, including library preparation kits and reagents for DNA and RNA sequencing. The company’s commitment to innovation is reflected in its ongoing investments in advancing NGS technologies, enabling researchers to achieve high-throughput and accurate results. Thermo Fisher Scientific, another significant player, offers a wide array of solutions that cater to diverse applications, including diagnostics and drug discovery. Their focus on integrating automation and data analysis tools into sample preparation workflows enhances the overall productivity and efficiency of laboratories. These companies are well-positioned to capitalize on the growing demand for NGS technologies, leveraging their established reputations and extensive distribution networks.

In addition to established players, several emerging companies are gaining traction within the market by introducing specialized and innovative sample preparation products. For instance, Oxford Nanopore Technologies has made notable advancements in real-time sequencing technologies, offering unique solutions that cater to specific research needs. Similarly, companies like Agilent Technologies and Qiagen are focusing on developing targeted sample preparation solutions that address the requirements of precision medicine and genomic research. As the market continues to evolve, the competitive landscape is likely to witness increased collaboration and consolidation, with companies seeking to enhance their capabilities and expand their market reach.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Qiagen N.V.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Illumina, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Macrogen, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Takara Bio, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 PerkinElmer, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Roche Diagnostics
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 107 Genomics, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Bioneer Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Zymo Research Corp.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Genomatix Software GmbH
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 New England Biolabs, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Agilent Technologies, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Bio-Rad Laboratories, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Oxford Nanopore Technologies Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Next Generation Sequencing Sample Preparation Market, By Application
    • 6.1.1 Diagnostics
    • 6.1.2 Drug Discovery
    • 6.1.3 Biomarker Discovery
    • 6.1.4 Agricultural & Animal Research
    • 6.1.5 Others
  • 6.2 Next Generation Sequencing Sample Preparation Market, By Product Type
    • 6.2.1 Library Preparation Kits
    • 6.2.2 DNA Fragmentation
    • 6.2.3 End Repair
    • 6.2.4 A-Tailing
    • 6.2.5 Size Selection
    • 6.2.6 Others
  • 6.3 Next Generation Sequencing Sample Preparation Market, By Distribution Channel
    • 6.3.1 Direct Sales
    • 6.3.2 Distributors
    • 6.3.3 Online Retail

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Next Generation Sequencing Sample Preparation Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Next Generation Sequencing Sample Preparation market is categorized based on

By Product Type

• Library Preparation Kits
• DNA Fragmentation
• End Repair
• A-Tailing
• Size Selection
• Others

By Application

• Diagnostics
• Drug Discovery
• Biomarker Discovery
• Agricultural & Animal Research
• Others

By Distribution Channel

• Direct Sales
• Distributors
• Online Retail

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Qiagen N.V.
• PerkinElmer, Inc.
• Roche Diagnostics
• New England Biolabs, Inc.
• Bio-Rad Laboratories, Inc.
• Genomatix Software GmbH
• Macrogen, Inc.
• Oxford Nanopore Technologies Ltd.
• Bioneer Corporation
• Zymo Research Corp.
• Takara Bio, Inc.
• 107 Genomics, Inc.